SEARCH RESULTS FOR: "Tag: BIIB"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(7)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(2)
Analyst Downgrades(4)
Analyst Update(10)
Analyst Upgrades(5)
Buzz Stocks(20)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(9)
Market Recap(1)
Midday Market Check(5)
Opening View(4)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(12)
Technical Analysis(1)

5/24/2019 10:55 AM
Biogen Inc (NASDAQ:BIIB) stock suffered its worst day in 14 years on March 21, when it gapped 29.2% lower on a pair of halted Alzheimer's disease drug trials. The shares have since struggled to surpas...
4/24/2019 9:58 AM
Drugmaker Biogen Inc (NASDAQ:BIIB) reported first-quarter earnings and revenue that exceeded analysts' expectations. The company cited strong growth from its spinal atrophy treatment, Spinraza, but s...
3/22/2019 2:56 PM
The Dow is getting crushed today due to the inverted yield curve and a rough outing from Nike (NKE). Of the stocks making particular noise today, mobile network firm Nokia Oyj (NYSE:NOK) is lower, wh...
3/22/2019 1:28 PM
The Dow Jones Industrial Average (DJI) is pacing for a weekly loss, which will mark its third in the past four weeks. A modestly bullish start to the week, which resulted in a "golden cross," was quic...
3/21/2019 10:32 AM
The shares of Biogen Inc (NASDAQ:BIIB) are plunging in today's trading, after the pharma giant and its partner Eisai halted two late-stage Alzheimer's disease drug trials. The decision came after an...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center